Create account

Coverage dated November 15, 2023

U.K. Greenlights World’s First Crispr Gene Editing Therapy

Headline from Forbes

The treatment, authorized for sickle cell disease and beta thalassemia, is being considered for approval by the FDA, with a decision expected in December.

Forbes's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.

Read the reports

Reports & sources

6 articles, oldest first.

  1. Time

    The World's First Approved CRISPR Treatment (opens Time)

    Published

    Time's feed description

    The U.K.'s drug regulator approved a gene therapy-based treatment for sickle cell disease and thalassemia.

  2. Forbes

    U.K. Greenlights World’s First Crispr Gene Editing Therapy (opens Forbes)

    Published

    Forbes's feed description

    The treatment, authorized for sickle cell disease and beta thalassemia, is being considered for approval by the FDA, with a decision expected in December.

  3. New York Times

    Sickle-Cell Treatment Created With Gene Editing Wins U.K. Approval (opens New York Times)

    Published

    New York Times's feed description

    The first treatment that relies on CRISPR is expected to receive U.S. approval next month. But it may cost millions of dollars per patient.

  4. Scientific American

    U.K. Becomes First Country to Approve a CRISPR Disease Treatment (opens Scientific American)

    Published

    Scientific American's feed description

    A newly approved CRISPR therapy could transform the treatment of sickle cell disease and beta-thalassemia—but the technology is expensive

  5. CNN

    UK regulators approve medical treatment involving CRISPR gene editing in world first (opens CNN)

    Published

    CNN's feed description

    The United Kingdom has become the first country to give regulatory approval to a medical treatment involving the revolutionary CRISPR gene editing tool.

Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.

U.K. Greenlights World’s First Crispr Gene Editing Therapy | Since Then